
High Containment Granulation Suite for GlaxoSmithKline
GSK required the development of a redeployed pilot-scale, high-containment granulation suite within an existing operational facility to OEB3 level of containment including an isolator around a high shear mixer. The suite needed to comply with ATEX regulations, enable low inlet-humidity operation, plus a requirement to integrate legacy equipment yet meet modern GMP and validation standards, all within tight budget and time constraints.